ERYTECH announces granting of new patent in the United States Post author:admERY Post published:October 20, 2014 Post category:Newsroom ERYTECH announces the granting of a new patent in the field of asparaginase in the United States. You Might Also Like ERYTECH submits EMA Marketing Authorization Application for GRASPA to treat acute lymphoblastic leukemia September 14, 2015 ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update September 10, 2018 ERYTECH announces presentation and webcast at the Jefferies 2015 Healthcare Conference June 2, 2015
ERYTECH submits EMA Marketing Authorization Application for GRASPA to treat acute lymphoblastic leukemia September 14, 2015
